InsidersTradesSigma
Browse the complete record of transactions filed by Sebaaly Camille, Chief Financial Officer. Insider active across 1 companies, notably Sunshine Biopharma, Inc. In total, 1 reports have been published. Total volume traded: €28k. The latest transaction was filed on 3 June 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Camille Sebaaly is the Chief Financial Officer and Secretary of Sunshine Biopharma, Inc., a biopharmaceutical company. In her role, she oversees financial operations and governance matters. Camille brings expertise in finance and business management, contributing to Sunshine's growth strategy.